☆ 4.7 Article

Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction

BRAIN BEHAVIOR AND IMMUNITY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Neurosciences

Olfactory loss and brain connectivity after COVID-19

Fabrizio Esposito et al.

Summary: This study analyzed the neural connectivity in the central olfactory system of individuals with persisting olfactory impairment due to COVID-19. The results showed that both the structural and functional connectivity were significantly increased in previously infected subjects compared to the control group. Greater residual olfactory impairment was associated with more segregated processing within certain regions. These findings suggest a characteristic brain connectivity response to residual hyposmia related to COVID-19.

HUMAN BRAIN MAPPING (2022)

添加到收藏夹

Article Otorhinolaryngology

Smell impairment in patients with chronic rhinosinusitis: a real-life study

Giulio Cesare Passali et al.

Summary: The study found that olfactory dysfunction is a common symptom in patients with chronic rhinosinusitis, especially in those with nasal polyps. After FESS surgery, there is a significant improvement in the sense of smell.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

添加到收藏夹

Article Neurosciences

Olfactory Dysfunction, Headache, and Mental Clouding in Adults with Long-COVID-19: What Is the Link between Cognition and Olfaction? A Cross-Sectional Study

Arianna Di Stadio et al.

Summary: Smell alteration and cognitive impairment are common features of the Long-COVID Syndrome. The present study investigated mental clouding, headache, and cognitive function in adult patients with persistent COVID-19 olfactory dysfunction. The findings suggest that headache and mental clouding are associated with more severe olfactory loss.

BRAIN SCIENCES (2022)

添加到收藏夹

Article Biology

Prokineticin-Receptor Network: Mechanisms of Regulation

Roberta Lattanzi et al.

Summary: This review summarizes the major cellular and biochemical mechanisms of prokineticins pathway regulation and discusses the potential for therapeutic intervention.

LIFE-BASEL (2022)

添加到收藏夹

Article Neurosciences

Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases

Daniela Maftei et al.

Summary: The immune system plays a crucial role in neurodegenerative diseases, and the chemokine PK2 is an important player in these diseases. The potential clinical value of PK2 as a disease biomarker or therapeutic target for Alzheimer's disease and Parkinson's disease is discussed.

CURRENT NEUROPHARMACOLOGY (2022)

添加到收藏夹

Article Otorhinolaryngology

Prevalence of acute olfactory dysfunction differs between variants of SARS-CoV-2-results from chemosensitive testing in wild type, VOC alpha (B.1.1.7) and VOC delta (B.1617.2)

Constantin A. Hintschich et al.

Summary: This study compared olfactory function in acute SARS-CoV-2 infection between the wild type virus and its variants alpha and delta, and found that patients with the wild type had a higher prevalence of olfactory impairment compared to patients with the variants.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Investigational drugs for the treatment of olfactory dysfunction

Arianna Di Stadio et al.

Summary: This review discusses the origin and treatment options for olfactory dysfunction, especially acquired olfactory loss related to COVID-19. Due to the difficulty in identifying the exact cause through clinical investigations, researchers speculate about the mechanisms of olfactory disorder based on the different results obtained from various treatment methods. They believe that these treatments might also be effective for olfactory diseases related to neurodegeneration.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health

Richard L. Doty

Summary: Decreased smell function is associated with brain health, mortality, and quality of life. Most COVID-19 patients experience some degree of smell dysfunction during the acute phase, with many being unaware of the loss. Long-term olfactory deficits occur in up to 30% of cases, but total anosmia is relatively rare. This review examines the nature and pathophysiology of olfactory dysfunction caused by the SARS-CoV-2 virus, including reversible inflammation in the olfactory cleft, downregulation of olfactory receptor proteins, and persistent damage to olfactory structures. It also addresses whether long-term smell loss may increase the risk of future cognitive and neurological deficits.

TRENDS IN MOLECULAR MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness of aprepitant in post-acute COVID19 syndrome

Rocio Reinoso-Arija et al.

Summary: This study presents the first case of a patient taking aprepitant for post-acute COVID-19 syndrome, which may inspire researchers to explore the efficacy and safety of a neurokinin 1 receptor antagonist in this common syndrome.

CLINICAL CASE REPORTS (2021)

添加到收藏夹

Review Clinical Neurology

COVID-19: dealing with a potential risk factor for chronic neurological disorders

Tommaso Schirinzi et al.

Summary: SARS-CoV2 infection can lead to acute and subacute neurological manifestations, such as encephalitis and stroke, and may potentially trigger chronic autoimmune and neurodegenerative disorders. Therefore, performing SARS-CoV2 serology when diagnosing these disorders could be beneficial in the future.

JOURNAL OF NEUROLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection

Rafal Butowt et al.

Summary: The prevalence of smell and taste dysfunction in COVID-19 differs between populations, possibly due to differences in virus strains or host proteins. Recent progress has been made in defining the cellular and molecular mechanisms of virus-induced anosmia, focusing on the role of sustentacular cells in the olfactory epithelium. The potential for using smell and taste dysfunctions as early diagnostic tools in COVID-19 is discussed.

NEUROSCIENTIST (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment

Riffat Mehboob

Summary: The COVID-19 pandemic requires urgent exploration of treatment strategies. This article proposes the potential use of Aprepitant in treating COVID-19 infection and highlights the importance of SP and NK-1R in drug development.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Letter Clinical Neurology

Increase of Prokineticin-2 in Serum of Patients with Parkinson's Disease

Tommaso Schirinzi et al.

MOVEMENT DISORDERS (2021)

添加到收藏夹

Article Behavioral Sciences

What substance P might tell us about the prognosis and mechanism of Parkinson's disease?

Paola Tirassa et al.

Summary: 【】The neuropeptide substance P is closely related to Parkinson's disease, particularly in non-motor symptoms, suggesting it may be a potential therapeutic target for PD.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes

Roberta Lattanzi et al.

Summary: The Prokineticin family, specifically Prokineticin 1 and Bv8/Prokineticin 2 (PROK2), interact with G protein-coupled receptors to regulate various biological functions in the central nervous system. Pathological insults can increase PROK2 expression levels and potentially contribute to neurodegenerative diseases. Despite documented physiological effects, the role of PROK2 and its receptors in neuropathological conditions remains unclear.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder

Ambra Stefani et al.

Summary: RT-QuIC detection of alpha-synuclein aggregates in olfactory mucosa showed a linkage between alpha-synuclein pathology and olfactory dysfunction in patients with isolated RBD and Parkinson's disease, indicating a potential for early detection and preventive therapies.

BRAIN (2021)

添加到收藏夹

Review Chemistry, Medicinal

Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients

Annalisa Noce et al.

Summary: The COVID-19 pandemic has caused over 100 million cases and 2 million deaths worldwide within a year. Palmitoylethanolamide (PEA) shows potential beneficial effects as an adjuvant therapy for SARS-CoV-2 infection, supported by ongoing clinical trials and studies showcasing its immunomodulatory, anti-inflammatory, neuroprotective, and pain-relieving effects.

PHARMACEUTICALS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury

Zhongyuan Bao et al.

Summary: Prokineticin-2 (Prok2) prevents neuronal cell ferroptosis after traumatic brain injury by regulating lipid peroxidation, and its administration before cortical injury reduces neuronal degeneration and improves motor and cognitive functions. This neuroprotective effect may be mediated through mechanisms involving Fbxo10.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Neurosciences

Neurodegeneration-Associated Proteins in Human Olfactory Neurons Collected by Nasal Brushing

Lorenzo Brozzetti et al.

FRONTIERS IN NEUROSCIENCE (2020)

添加到收藏夹

Article Neurosciences

The PROK2/PROKR2 signaling pathway is required for the migration of most olfactory bulb interneurons

Yan Wen et al.

JOURNAL OF COMPARATIVE NEUROLOGY (2019)

添加到收藏夹

Article Cell Biology

Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human Pathology

Roberta Lattanzi et al.

CELLS (2019)

添加到收藏夹

Article Endocrinology & Metabolism

PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor

Roberta Lattanzi et al.

NEUROPEPTIDES (2018)

添加到收藏夹

Review Physiology

THE PROKINETICINS: NEUROMODULATORS AND MEDIATORS OF INFLAMMATION AND MYELOID CELL-DEPENDENT ANGIOGENESIS

Lucia Negri et al.

PHYSIOLOGICAL REVIEWS (2018)

添加到收藏夹

Article Neurosciences

Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes

Matthew Neal et al.

GLIA (2018)

添加到收藏夹

Article Otorhinolaryngology

Nasal symptoms, epithelial injury and neurogenic inflammation in elite swimmers

Brecht Steelant et al.

RHINOLOGY (2018)

添加到收藏夹

Review Neurosciences

The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders

M. Brittany Johnson et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

Neuropeptide substance P and the immune response

Alireza Mashaghi et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration

Richard Gordon et al.

NATURE COMMUNICATIONS (2016)

添加到收藏夹

Article Otorhinolaryngology

How to assess olfactory performance with the Sniffin' Sticks test®

C. Rumeau et al.

EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES (2016)

添加到收藏夹

Article Neurosciences

Substance P Exacerbates Dopaminergic Neurodegeneration through Neurokinin-1 Receptor-Independent Activation of Microglial NADPH Oxidase

Qingshan Wang et al.

JOURNAL OF NEUROSCIENCE (2014)

添加到收藏夹

Article Medicine, General & Internal

A Test for Creutzfeldt-Jakob Disease Using Nasal Brushings

Christina D. Orru et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases

Francesca Tavano et al.

DIGESTIVE AND LIVER DISEASE (2013)

添加到收藏夹

Review Cell Biology

Peripheral modulation of smell: Fact or fiction?

Mary T. Lucero

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2013)

添加到收藏夹

Article Neurosciences

Mitochondrial Ca2+ mobilization is a key element in olfactory signaling

Daniela Fluegge et al.

NATURE NEUROSCIENCE (2012)

添加到收藏夹

Article Neurosciences

Expression of prokineticins and their receptors in the adult mouse brain

Michelle Y. Cheng et al.

JOURNAL OF COMPARATIVE NEUROLOGY (2006)

添加到收藏夹

Article Multidisciplinary Sciences

Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling

KL Ng et al.

SCIENCE (2005)

添加到收藏夹

Review Pharmacology & Pharmacy

The tachykinin peptide family

C Severini et al.

PHARMACOLOGICAL REVIEWS (2002)

添加到收藏夹

Article Biochemistry & Molecular Biology

Substance P and calcitonin gene-related peptide increase IL-1β, IL-6 and TNFα secretion from human peripheral blood mononuclear cells

MC Cuesta et al.

NEUROCHEMISTRY INTERNATIONAL (2002)

添加到收藏夹

Article Neurosciences

Trigeminal collaterals in the nasal epithelium and olfactory bulb:: A potential route for direct modulation of olfactory information by trigeminal stimuli

ML Schaefer et al.

JOURNAL OF COMPARATIVE NEUROLOGY (2002)

添加到收藏夹

Article Cell Biology

Substance P induced histamine release from nasal mucosa of subjects with and without allergic rhinitis

G Hanf et al.

INFLAMMATION RESEARCH (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.